EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012–2020)

Ivailo Alexiev iD, Anupama Shankar, Yi Pan, Lyubomira Grigorova, Alexandra Partsuneva, Reneta Dimitrova iD, Anna Gancheva, Asya Kostadinova, Ivaylo Elenkov, Nina Yancheva iD, Rusina Grozdeva, Dimitar Strashimirov und 8 weitere

Viruses · 2023

DOI: 10.3390/v15040941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Ivailo Alexiev und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, HIV-1, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, National Program for Prevention and Control of HIV and Sexually Transmitted Infections in Bulgaria, by the European Regional Development Fu….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmitted HIV drug resistance in Bulgaria was first reported in 2015 using data from 1988–2011. We determined the prevalence of surveillance drug resistance mutations (SDRMs) and HIV-1 genetic diversity in Bulgaria during 2012–2020 using polymerase sequences from 1053 of 2010 (52.4%) antiretroviral therapy (ART)-naive individuals. Sequences were analyzed for DRM using the WHO HIV SDRM list implemented in the calculated population resistance tool at Stanford University. Genetic diversity was inferred using automated subtyping tools and phylogenetics. Cluster detection and characterization was performed using MicrobeTrace. The overall rate of SDRMs was 5.7% (60/1053), with 2.2% having resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 1.8% to non-nucleoside reverse transcriptase inhibitors (NNRTIs), 2.1% to protease inhibitors (PIs), and 0.4% with dual-class SDRMs. We found high HIV-1 diversity, with the majority being subtype B (60.4%), followed by F1 (6.9%), CRF02_AG (5.2%), A1 (3.7%), CRF12_BF (0.8%), and other subtypes and recombinant forms (23%). Most (34/60, 56.7%) of the SDRMs were present in transmission clusters of different subtypes composed mostly of male-to-male sexual contact (MMSC), including a 14-member cluster of subtype B sequences from 12 MMSC and two males reporting heterosexual contact; 13 had the L90M PI mutation and one had the T215S NRTI SDRM. We found a low SDRM prevalence amid high HIV-1 diversity among ART-naive patients in Bulgaria during 2012–2020. The majority of SDRMs were found in transmission clusters containing MMSC, indicative of onward spread of SDRM in drug-naive individuals. Our study provides valuable information on the transmission dynamics of HIV drug resistance in the context of high genetic diversity in Bulgaria, for the development of enhanced prevention strategies to end the epidemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV SeropositivityHIV-1Anti-HIV AgentsHumansMaleReverse Transcriptase InhibitorsBulgariaDrug Resistance, ViralMutationPrevalencePhylogenyGenotypeMethionineSulfonium Compounds

Stichwörter der Autor:innen

HIV-1male-to-male sexual contactsubtypestransmission clusterstransmitted drug resistance

Substanzen

Reverse Transcriptase InhibitorsAnti-HIV Agentsmethionylmethylsulfonium chlorideMethionineSulfonium Compounds

Autor:innen und Institutionen

  • National Reference Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria.
  • Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Specialized Hospital for Active Treatment of Infectious & Parasitic Diseases, 1606 Sofia, Bulgaria.
  • Department of Infectious Diseases, Medical University, 4002 Plovdiv, Bulgaria.
  • Department of Infectious Diseases, Medical University, 5800 Pleven, Bulgaria.
  • Clinic of Infectious Diseases, Medical University, 6000 Stara Zagora, Bulgaria.

ORCID-Profile: Ivailo Alexiev, Reneta Dimitrova, Nina Yancheva, Radoslava Emilova, William M Switzer

Förderung

  • Ministry of Health, National Program for Prevention and Control of HIV and Sexually Transmitted Infections in Bulgaria, by the European Regional Development Fu…

Zitieren

APA

Alexiev, I., Shankar, A., Pan, Y., Grigorova, L., Partsuneva, A., Dimitrova, R., Gancheva, A., Kostadinova, A., Elenkov, I., Yancheva, N., Grozdeva, R., Strashimirov, D., Stoycheva, M., Baltadzhiev, I., Doichinova, T., Pekova, L., Kosmidis, M., Emilova, R., Nikolova, M., & Switzer, W. M. (2023). Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012–2020). Viruses. https://doi.org/10.3390/v15040941

Vancouver

Alexiev I, Shankar A, Pan Y, Grigorova L, Partsuneva A, Dimitrova R, et al. Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012–2020). Viruses. 2023. doi:10.3390/v15040941

BibTeX
@article{Alexiev2023,
  author = {Alexiev, Ivailo and Shankar, Anupama and Pan, Yi and Grigorova, Lyubomira and Partsuneva, Alexandra and Dimitrova, Reneta and Gancheva, Anna and Kostadinova, Asya and Elenkov, Ivaylo and Yancheva, Nina and Grozdeva, Rusina and Strashimirov, Dimitar and Stoycheva, Mariana and Baltadzhiev, Ivan and Doichinova, Tsetsa and Pekova, Lilia and Kosmidis, Minas and Emilova, Radoslava and Nikolova, Maria and Switzer, William M},
  title = {Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012–2020)},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040941}
}
Kostenlos starten →